Answers are grounded in this paper and cite their sources.
Multiomics profiling of ovarian tumor samples pre- and post-NACT provides unique insight into chemo-induced changes to the tumor microenvironment. We identified a novel IL6/IER3 signaling axis that may drive chemoresistance and disease recurrence.
No takes yet. Share an insight, caveat, or question.
Jordan et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: